Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project.

Morbelli S, Drzezga A, Perneczky R, Frisoni GB, Caroli A, van Berckel BN, Ossenkoppele R, Guedj E, Didic M, Brugnolo A, Sambuceti G, Pagani M, Salmon E, Nobili F.

Neurobiol Aging. 2012 Nov;33(11):2533-50. doi: 10.1016/j.neurobiolaging.2012.01.005. Epub 2012 Feb 23.

PMID:
22365486
2.

Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease.

Fouquet M, Desgranges B, Landeau B, Duchesnay E, Mézenge F, de la Sayette V, Viader F, Baron JC, Eustache F, Chételat G.

Brain. 2009 Aug;132(Pt 8):2058-67. doi: 10.1093/brain/awp132. Epub 2009 May 28.

3.

Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European Alzheimer disease consortium project.

Morbelli S, Perneczky R, Drzezga A, Frisoni GB, Caroli A, van Berckel BN, Ossenkoppele R, Guedj E, Didic M, Brugnolo A, Naseri M, Sambuceti G, Pagani M, Nobili F.

J Nucl Med. 2013 Jun;54(6):894-902. doi: 10.2967/jnumed.112.113928. Epub 2013 Apr 16.

4.

Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairment.

Wu X, Chen K, Yao L, Ayutyanont N, Langbaum JB, Fleisher A, Reschke C, Lee W, Liu X, Alexander GE, Bandy D, Foster NL, Thompson PM, Harvey DJ, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM; Alzheimer's Disease Neuroimaging Initiative.

J Neurosci Methods. 2010 Oct 15;192(2):277-85. doi: 10.1016/j.jneumeth.2010.07.030. Epub 2010 Aug 1.

5.

Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.

Laforce R Jr, Tosun D, Ghosh P, Lehmann M, Madison CM, Weiner MW, Miller BL, Jagust WJ, Rabinovici GD.

Neuroimage Clin. 2014 Mar 19;4:508-16. doi: 10.1016/j.nicl.2014.03.005. eCollection 2014.

6.

MCI patients declining and not-declining at mid-term follow-up: FDG-PET findings.

Pagani M, Dessi B, Morbelli S, Brugnolo A, Salmaso D, Piccini A, Mazzei D, Villavecchia G, Larsson SA, Rodriguez G, Nobili F.

Curr Alzheimer Res. 2010 Jun;7(4):287-94.

PMID:
19939228
7.

Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease.

Chételat G, Desgranges B, Landeau B, Mézenge F, Poline JB, de la Sayette V, Viader F, Eustache F, Baron JC.

Brain. 2008 Jan;131(Pt 1):60-71. Epub 2007 Dec 5.

PMID:
18063588
8.

Relationship between baseline brain metabolism measured using [¹⁸F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease.

Habeck C, Risacher S, Lee GJ, Glymour MM, Mormino E, Mukherjee S, Kim S, Nho K, DeCarli C, Saykin AJ, Crane PK; Alzheimer’s Disease Neuroimaging Initiative.

Brain Imaging Behav. 2012 Dec;6(4):568-83. doi: 10.1007/s11682-012-9208-x.

9.

Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.

Ossenkoppele R, Zwan MD, Tolboom N, van Assema DM, Adriaanse SF, Kloet RW, Boellaard R, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, van der Flier WM, van Berckel BN.

Brain. 2012 Jul;135(Pt 7):2115-25. doi: 10.1093/brain/aws113. Epub 2012 May 3.

PMID:
22556189
10.

Individual cerebral metabolic deficits in Alzheimer's disease and amnestic mild cognitive impairment: an FDG PET study.

Del Sole A, Clerici F, Chiti A, Lecchi M, Mariani C, Maggiore L, Mosconi L, Lucignani G.

Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1357-66. doi: 10.1007/s00259-008-0773-6. Epub 2008 Apr 17.

PMID:
18418593
11.

Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study.

Pagani M, De Carli F, Morbelli S, Öberg J, Chincarini A, Frisoni GB, Galluzzi S, Perneczky R, Drzezga A, van Berckel BN, Ossenkoppele R, Didic M, Guedj E, Brugnolo A, Picco A, Arnaldi D, Ferrara M, Buschiazzo A, Sambuceti G, Nobili F.

Neuroimage Clin. 2014 Nov 18;7:34-42. doi: 10.1016/j.nicl.2014.11.007. eCollection 2015.

12.

Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease.

Hunt A, Schönknecht P, Henze M, Seidl U, Haberkorn U, Schröder J.

Psychiatry Res. 2007 Jul 15;155(2):147-54. Epub 2007 May 23.

PMID:
17524628
13.

Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.

Küntzelmann A, Guenther T, Haberkorn U, Essig M, Giesel F, Henze R, Schroeter ML, Schröder J, Schönknecht P.

Neurosci Lett. 2013 Feb 8;534:12-7. doi: 10.1016/j.neulet.2012.11.026. Epub 2012 Nov 23.

PMID:
23182881
14.

Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.

Ito K, Shimano Y, Imabayashi E, Nakata Y, Omachi Y, Sato N, Arima K, Matsuda H.

Int J Geriatr Psychiatry. 2014 Oct;29(10):1079-86. doi: 10.1002/gps.4102. Epub 2014 Mar 29.

PMID:
24687634
15.

Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Langbaum JB, Chen K, Lee W, Reschke C, Bandy D, Fleisher AS, Alexander GE, Foster NL, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2009 May 1;45(4):1107-16. doi: 10.1016/j.neuroimage.2008.12.072. Epub 2009 Jan 21.

16.

Executive deficits and regional brain metabolism in Alzheimer's disease.

Woo BK, Harwood DG, Melrose RJ, Mandelkern MA, Campa OM, Walston A, Sultzer DL.

Int J Geriatr Psychiatry. 2010 Nov;25(11):1150-8. doi: 10.1002/gps.2452.

PMID:
20069587
17.

Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden.

Drzezga A, Becker JA, Van Dijk KR, Sreenivasan A, Talukdar T, Sullivan C, Schultz AP, Sepulcre J, Putcha D, Greve D, Johnson KA, Sperling RA.

Brain. 2011 Jun;134(Pt 6):1635-46. doi: 10.1093/brain/awr066. Epub 2011 Apr 13.

18.

Visual versus semi-quantitative analysis of 18F-FDG-PET in amnestic MCI: an European Alzheimer's Disease Consortium (EADC) project.

Morbelli S, Brugnolo A, Bossert I, Buschiazzo A, Frisoni GB, Galluzzi S, van Berckel BN, Ossenkoppele R, Perneczky R, Drzezga A, Didic M, Guedj E, Sambuceti G, Bottoni G, Arnaldi D, Picco A, De Carli F, Pagani M, Nobili F.

J Alzheimers Dis. 2015;44(3):815-26. doi: 10.3233/JAD-142229.

PMID:
25362041
19.

Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease.

Anchisi D, Borroni B, Franceschi M, Kerrouche N, Kalbe E, Beuthien-Beumann B, Cappa S, Lenz O, Ludecke S, Marcone A, Mielke R, Ortelli P, Padovani A, Pelati O, Pupi A, Scarpini E, Weisenbach S, Herholz K, Salmon E, Holthoff V, Sorbi S, Fazio F, Perani D.

Arch Neurol. 2005 Nov;62(11):1728-33.

PMID:
16286547
20.

Prevalence and prognosis of prodromal Alzheimer's disease as assessed by magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography in a community: reanalysis from the Osaki-Tajiri Project.

Meguro K, Akanuma K, Meguro M, Yamaguchi S, Ishii H, Tashiro M.

Psychogeriatrics. 2016 Mar;16(2):116-20. doi: 10.1111/psyg.12131. Epub 2015 Jun 26.

Supplemental Content

Support Center